Will Cyramza with health insurance benefits broaden options for stomach cancer patients?

Published: 2018-05-04 17:07:42

Updated: 2018-05-04 17:08:00

Will ‘Cyramza(generic name: ramucirumab),’ a secondary treatment for stomach cancer, break the wall of health insurance benefits and become a practical treatment option for stomach cancer patients?

Lilly Korea, on the 2^nd, held a press conference to celebrate the Korean health insurance benefits of Cyramza, a secondary treatment for progressive and metastatic stomach cancer patients.

There ha...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.